A Review of the Applications of Tissue Microarray Technology in Understanding the Molecular Features of Endometrial Carcinoma

Judit Pallares, Maria Santacana, Soraya Puente, Susana Lopez, Andree Yeramian, Nuria Eritja, Anabel Sorolla, David Llobet, Xavier Dolcet, Xavier Matias-Guiu

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

OBJECTIVE: To review the literature regarding the use of tissue microarray (TMA) technology in understanding the biology, diagnosis and prognosis of endometrial carcinoma (EC).

STUDY DESIGN: This review of TMA technology in EC was based on a large number of published articles. We focused on the use of TMA technology a a tool to gain insight in endometrial carcinogenesis and to validate data obtained from DNA microarrays, proteomics and cellular models.

RESULTS: We summarized the technical aspects of the 37 articles that were reviewed. The number of EC cases in each series varied from 32-485 (median, 128). The number of cores ranged from 1-4 (median, 2), and the size of the cores ranged from 0.6-2 mm (median, 0.6 mm). Only 3 studies applied fluorescence in situ hybridization technology, while the remaining 34 studies used immunohistochemistry.

CONCLUSION: TMA can help to establish new prognostic markers and to define protein biomarkers that help in differential diagnosis. (Anal Quant Cytol Histol 2009;31:217-226)

Original languageEnglish
Pages (from-to)217-226
Number of pages10
JournalAnalytical and quantitative cytology and histology
Volume31
Issue number4
Publication statusPublished - Aug 2009

Cite this